Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PYC THERAPEUTICS LIMITED Director's Dealing 2018

Sep 20, 2018

65640_rns_2018-09-20_0b591015-5dcf-474c-99b5-b28d80866dfe.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Phylogica Limited
ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Alan William TRIBE
Date of last notice 12 April 2018

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Mr Tribe is a Director of AustralianLand Pty Ltd
Date of change 21 September 2018
No. of securities held prior to change
Direct Nil
Indirect Australian Land Pty Ltd (ACN 008 808 517) 425,766,247 ordinary shares
Class Fully paid ordinary shares
Number acquired 9,000,000
Number disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation $0.0285per ordinary share
No. of securities held after change
Direct Nil
Indirect Australian Land Pty Ltd (ACN 008 808 517) 434,766,247 ordinary shares

+ See chapter 19 for defined terms.

Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back Off-market trade

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
Date of change N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relation to which theinterest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation N/A
Interest after change N/A

Part 3 – +Closed period

Were the interests in the securities or contracts No
detailed above traded during a +closed periodwhere
prior written clearance was required?
If so, was prior written clearance provided to allow the N/A
trade to proceed during this period?
If prior written clearance was provided, on what datewas this provided? N/A

+ See chapter 19 for defined terms.